WuXi Biologics and ImmuneOncia Sign MOU for Development and Manufacturing of Anti-PD-L1/CD47 Bispecific Antibody Read more
Novavax Submits Final Data Packages to U.S. FDA as Prerequisite to Emergency Use Authorization Application Request for COVID-19 Vaccine Read more
Karyopharm and Menarini Group Enter into Exclusive License Agreement to Commercialize NEXPOVIO (selinexor) in Europe and Other Key Global Territories Read more